Ambagon Therapeutics

0 followers

‌

Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.

Industries

Analytics, Biotechnology

Headquarters

San Francisco, United States

Employees

11-50

Links

Org chart

Willem van den Hout

Research Associate, Biochemistry

Rens de Vries

Scientist, Structural Biology

Associate Scientist

Scientist

Senior Scientist

Associate Scientist

Senior Scientist

Research Associate, Structural Biology

Loes Stevers

Principal Scientist Biochemistry

Paul Hollenbach

Scientist

Donna Olivia Debets

Senior Scientist Proteomics

Michelle Pazmino

Senior Research Associate

Taggra Jackson

Sr. Research Associate

Tanja Meyer

VP & Head, Corporate Strategy & Business Development

Teams

+12

Scientific Research Team

15 members

Directors Team

7 members

Scientific Advisory Team

7 members

Leadership Team

1 members

Similar companies

Enko

4 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Tango Therapeutics

2 followers

Kyverna Therapeutics

6 followers

Ultima Genomics

3 followers

Cellares

2 followers

DNAnexus

6 followers

eGenesis

1 follower

Bigeye

3 followers

BioXcellerator

1 follower

Explore companies